Aspreva Pharmaceuticals
Aspreva obtains shareholder approval for acquisition by Galenica
Published in Drug Law Weekly, January 1st, 2008
Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV) announced that Aspreva's shareholders and optionholders have approved the proposed acquisition of Aspreva by Galenica Group , through a wholly-owned Canadian subsidiary, at a price of US$26.00 per share in cash. At the special meeting of securityholders held this morning, the transaction was approved by over 99% of the votes cast by shareholders and by over 99% of the votes cast by shareholders and optionholders, voting together as a class.
The transaction is being carried out by way of a statutory plan of arrangement under Section 288 of the British Columbia Business Corporations Act. The closing of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2008-01-01)
More Articles from Drug Law Weekly
- Adverse Drug Reactions
Scientists at University of California publish research in adverse drug reactions - American Veterinary Medical Association
AVMA Lauds Senators for Approving 2007 Farm Bill Legislation that Includes the Veterinary Workforce Grant Program - Aspreva Pharmaceuticals
Aspreva receives final court approval for acquisition by Galenica - Biopharmaceuticals
AVI BioPharma, Inc. Completes Registered Direct Offering, Raises $20.3 Million - Biopharmaceuticals
Otsuka Pharmaceutical Acquires Rights to IV Busulfex from PDL BioPharma - Biotechnology
Cougar Biotechnology Announces $87 Million Private Placement - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
